US Stock MarketDetailed Quotes

Dianthus Therapeutics (DNTH)

Watchlist
  • 86.150
  • -0.970-1.11%
Close May 12 16:00 ET
  • 86.150
  • 0.0000.00%
Post 16:10 ET
4.71BMarket Cap-20.37P/E (TTM)

Dianthus Therapeutics (DNTH) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-60.19%463K
-67.35%2.04M
-78.58%284K
-81.77%396K
-89.64%193K
33.07%1.16M
120.63%6.24M
190.15%1.33M
135.06%2.17M
92.26%1.86M
Operating revenue
-60.19%463K
-67.35%2.04M
-78.58%284K
-81.77%396K
-89.64%193K
33.07%1.16M
120.63%6.24M
190.15%1.33M
135.06%2.17M
92.26%1.86M
Cost of revenue
Gross profit
Operating expense
36.85%47M
66.49%179.97M
110.05%69.83M
26.85%40.68M
45.93%35.12M
83.46%34.34M
111.96%108.1M
147.83%33.24M
92.24%32.07M
88.83%24.07M
Selling and administrative expenses
69.93%12.47M
37.36%34.33M
45.41%9.93M
25.54%8.2M
47.89%8.87M
30.09%7.34M
37.64%24.99M
47.43%6.83M
-25.16%6.53M
140.65%6M
-General and administrative expense
69.93%12.47M
37.36%34.33M
45.41%9.93M
25.54%8.2M
47.89%8.87M
30.09%7.34M
37.64%24.99M
47.43%6.83M
-25.16%6.53M
140.65%6M
Research and development costs
27.87%34.53M
75.25%145.64M
126.76%59.9M
27.19%32.49M
45.27%26.25M
106.48%27M
153.05%83.11M
200.80%26.41M
220.90%25.54M
76.24%18.07M
Operating profit
-40.26%-46.53M
-74.68%-177.93M
-117.89%-69.54M
-34.74%-40.29M
-57.30%-34.93M
-85.93%-33.18M
-111.45%-101.86M
-146.34%-31.92M
-89.73%-29.9M
-88.55%-22.2M
Net non-operating interest income expense
65.26%6.27M
-7.18%16.12M
32.01%5.27M
-17.71%3.66M
-27.72%3.4M
-10.21%3.79M
264.50%17.37M
63.26%3.99M
332.81%4.45M
585.30%4.71M
Non-operating interest income
65.26%6.27M
-7.18%16.12M
32.01%5.27M
-17.71%3.66M
-27.72%3.4M
-10.21%3.79M
264.50%17.37M
63.26%3.99M
332.81%4.45M
585.30%4.71M
Other net income (expense)
-352.80%-566K
-11.28%-523K
69.26%-158K
-148.04%-135K
5.41%-105K
0.79%-125K
-224.14%-470K
-907.84%-514K
1,006.45%281K
-117.65%-111K
Gain on sale of security
-1,074.07%-317K
436.90%451K
290.15%251K
-13.13%225K
106.45%2K
-125.00%-27K
198.82%84K
-312.50%-132K
1,718.75%259K
-10.71%-31K
Other non- operating income (expenses)
-154.08%-249K
-75.81%-974K
-7.07%-409K
-1,736.36%-360K
-33.75%-107K
14.04%-98K
-823.33%-554K
-1,910.53%-382K
246.67%22K
-247.83%-80K
Income before tax
-38.37%-40.83M
-91.05%-162.34M
-126.55%-64.43M
-46.04%-36.77M
-79.64%-31.63M
-114.66%-29.51M
-95.08%-84.97M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
Income tax
Net income
-38.37%-40.83M
-91.05%-162.34M
-126.55%-64.43M
-46.04%-36.77M
-79.64%-31.63M
-114.66%-29.51M
-95.08%-84.97M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
Net income continuous Operations
-38.37%-40.83M
-91.05%-162.34M
-126.55%-64.43M
-46.04%-36.77M
-79.64%-31.63M
-114.66%-29.51M
-95.08%-84.97M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
Minority interest income
Net income attributable to the parent company
-38.37%-40.83M
-91.05%-162.34M
-126.55%-64.43M
-46.04%-36.77M
-79.64%-31.63M
-114.66%-29.51M
-95.08%-84.97M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.37%-40.83M
-91.05%-162.34M
-126.55%-64.43M
-46.04%-36.77M
-79.64%-31.63M
-114.66%-29.51M
-95.08%-84.97M
-169.24%-28.44M
-70.52%-25.17M
-58.05%-17.61M
Basic earnings per share
-3.66%-0.85
-64.71%-4.2
-76.54%-1.43
-31.08%-0.97
-72.55%-0.88
-51.85%-0.82
69.82%-2.55
-13.63%-0.81
80.42%-0.74
32.16%-0.51
Diluted earnings per share
-3.66%-0.85
-64.71%-4.2
-76.54%-1.43
-31.08%-0.97
-72.55%-0.88
-51.85%-0.82
69.82%-2.55
-13.63%-0.81
80.42%-0.74
32.16%-0.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -60.19%463K-67.35%2.04M-78.58%284K-81.77%396K-89.64%193K33.07%1.16M120.63%6.24M190.15%1.33M135.06%2.17M92.26%1.86M
Operating revenue -60.19%463K-67.35%2.04M-78.58%284K-81.77%396K-89.64%193K33.07%1.16M120.63%6.24M190.15%1.33M135.06%2.17M92.26%1.86M
Cost of revenue
Gross profit
Operating expense 36.85%47M66.49%179.97M110.05%69.83M26.85%40.68M45.93%35.12M83.46%34.34M111.96%108.1M147.83%33.24M92.24%32.07M88.83%24.07M
Selling and administrative expenses 69.93%12.47M37.36%34.33M45.41%9.93M25.54%8.2M47.89%8.87M30.09%7.34M37.64%24.99M47.43%6.83M-25.16%6.53M140.65%6M
-General and administrative expense 69.93%12.47M37.36%34.33M45.41%9.93M25.54%8.2M47.89%8.87M30.09%7.34M37.64%24.99M47.43%6.83M-25.16%6.53M140.65%6M
Research and development costs 27.87%34.53M75.25%145.64M126.76%59.9M27.19%32.49M45.27%26.25M106.48%27M153.05%83.11M200.80%26.41M220.90%25.54M76.24%18.07M
Operating profit -40.26%-46.53M-74.68%-177.93M-117.89%-69.54M-34.74%-40.29M-57.30%-34.93M-85.93%-33.18M-111.45%-101.86M-146.34%-31.92M-89.73%-29.9M-88.55%-22.2M
Net non-operating interest income expense 65.26%6.27M-7.18%16.12M32.01%5.27M-17.71%3.66M-27.72%3.4M-10.21%3.79M264.50%17.37M63.26%3.99M332.81%4.45M585.30%4.71M
Non-operating interest income 65.26%6.27M-7.18%16.12M32.01%5.27M-17.71%3.66M-27.72%3.4M-10.21%3.79M264.50%17.37M63.26%3.99M332.81%4.45M585.30%4.71M
Other net income (expense) -352.80%-566K-11.28%-523K69.26%-158K-148.04%-135K5.41%-105K0.79%-125K-224.14%-470K-907.84%-514K1,006.45%281K-117.65%-111K
Gain on sale of security -1,074.07%-317K436.90%451K290.15%251K-13.13%225K106.45%2K-125.00%-27K198.82%84K-312.50%-132K1,718.75%259K-10.71%-31K
Other non- operating income (expenses) -154.08%-249K-75.81%-974K-7.07%-409K-1,736.36%-360K-33.75%-107K14.04%-98K-823.33%-554K-1,910.53%-382K246.67%22K-247.83%-80K
Income before tax -38.37%-40.83M-91.05%-162.34M-126.55%-64.43M-46.04%-36.77M-79.64%-31.63M-114.66%-29.51M-95.08%-84.97M-169.24%-28.44M-70.52%-25.17M-58.05%-17.61M
Income tax
Net income -38.37%-40.83M-91.05%-162.34M-126.55%-64.43M-46.04%-36.77M-79.64%-31.63M-114.66%-29.51M-95.08%-84.97M-169.24%-28.44M-70.52%-25.17M-58.05%-17.61M
Net income continuous Operations -38.37%-40.83M-91.05%-162.34M-126.55%-64.43M-46.04%-36.77M-79.64%-31.63M-114.66%-29.51M-95.08%-84.97M-169.24%-28.44M-70.52%-25.17M-58.05%-17.61M
Minority interest income
Net income attributable to the parent company -38.37%-40.83M-91.05%-162.34M-126.55%-64.43M-46.04%-36.77M-79.64%-31.63M-114.66%-29.51M-95.08%-84.97M-169.24%-28.44M-70.52%-25.17M-58.05%-17.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.37%-40.83M-91.05%-162.34M-126.55%-64.43M-46.04%-36.77M-79.64%-31.63M-114.66%-29.51M-95.08%-84.97M-169.24%-28.44M-70.52%-25.17M-58.05%-17.61M
Basic earnings per share -3.66%-0.85-64.71%-4.2-76.54%-1.43-31.08%-0.97-72.55%-0.88-51.85%-0.8269.82%-2.55-13.63%-0.8180.42%-0.7432.16%-0.51
Diluted earnings per share -3.66%-0.85-64.71%-4.2-76.54%-1.43-31.08%-0.97-72.55%-0.88-51.85%-0.8269.82%-2.55-13.63%-0.8180.42%-0.7432.16%-0.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More